Transjugular intrahepatic portosystemic stent-shunt after orthotopic liver transplantation in a patient with early recurrence of portal hypertension of unknown origin

Zeitschrift fur Gastroenterologie

Volumn 36, Issue 2, 1998, Pages 159-164

  Nolte, W ^a   Canelo, R ^a   Figulla, H R ^a   Kersten, J ^a   Sattler, B ^a   Munke H ^a   Hartmann, H ^a   Ringe, B ^a   Ramadori, G ^a,b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b Abteihatg Gastroenterol/Endokrinol   (Germany)

Author keywords

Hepatitis C virus infection; Liver transplantation; Portal hypertension; Refractory ascites; Transjugular intrahepatic portosystemic stent shunt (TIPS)

Indexed keywords

AGED; ARTICLE; ASCITES; CASE REPORT; ECHOGRAPHY; ESOPHAGUS VARICES; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IDIOPATHIC DISEASE; LIVER ANGIOGRAPHY; LIVER TRANSPLANTATION; MALE; PORTAL HYPERTENSION; PORTAL PHLEBOGRAPHY; PORTOSYSTEMIC ANASTOMOSIS;

AGED; BIOPSY; ESOPHAGEAL AND GASTRIC VARICES; FOLLOW-UP STUDIES; GASTROINTESTINAL HEMORRHAGE; HEPATITIS C; HUMANS; HYPERTENSION, PORTAL; LIVER; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; MALE; PERITONEOVENOUS SHUNT; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; POSTOPERATIVE COMPLICATIONS; RECURRENCE; REOPERATION;

EID: 0031918456     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Pichlmayr R, Lang H, Oldhafer KJ. Liver grafting in portal hypertension. In: Holstege A, Schölmerich J, Hahn EG (eds.). Portal Hypertension, Falk symposium 79. Dordrecht/Boston/London, Kluwer Academic Publishers 1995; 441-50
2. Croszman, RJ. Hyperdynamic state in chronic liver diseases. J Hepatol 1993; 17: S38-S40
3. Hadengue A, Lebrec D. Moreau R et al. Persistence of systemic and splanchnic hyperkinetic circulation in liver transplant patients. Hepatology 1993; 17: 175-8
4. Henderson JM. Abnormal splanchnic and systemic hemodynamics of end-stage liver disease: What happens after liver transplantation? Hepatology 1993; 17: 514-6
5. Lauler DP. An overview of the pathophysiology and management of portal hypertension and ascites. J Hepatol 1993; 17: 1-3
6. Nolte W, Hartmann H, Ramadori G. Portale Hypertension - Pathophysiologie und Therapieansätze. Z Gastroenterol 1994; 32: 447-59
7. Nolte W, Wiltfang J-G, Kunert H-J et al. Erste klinische Erfahrungen mit TIPS (transjugulärer intrahepatischer portosystemischer Stent-Shunt). Leber Magen Darm 1995; 25: 264-70
8. Ochs A, Rössle M. Haag K et al. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites. N Engl J Med 1995; 332: 1192-7
9. Rössle M, Haag K, Ochs A et al. The transjugular intrahepatic portsystemic stent-shunt procedure for variceal bleeding. N Engl J Med 1994; 330: 165-71
10. Shiffman MI, Jeffers L, Hoofnagle JH, Tralka TS. The role of transjugular intrahepatic portosystemic shunt for treatment of portal hypertension and its complications: A conference sponsored by the national digestive diseases advisory board. Hepatology 1995; 22: 1591-7
11. Crecelius SA, Soulen MC. Transjugular intrahepatic portsystemic shunts for portal hypertension. Gastroenterol Clin North Am 1995; 24: 201-19
12. Lerut J, Mourad M, Bourlier P et al. Transjugular portosystemic stent shunting in liver transplanted patients. Hepatology 1994; 20: 370A
13. Arroyo V, Cines P, Gerbes AI et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology 1996; 23: 164-76
14. Cane EJ, Langley P, Williams R. Massive ascitic fluid loss and coagulation disturbances after liver transplantation. Gastroenterology 1995; 109: 1631-8
15. Gadano A, Hadengue A, Widmann JJ et al. Hemodynamics after orthotopic liver transplantation: Study of associated factors and long-term effects. Hepatology 1995; 22: 458-65
16. Navasa M, Feu F, García-Pagán JC et al. Hemodynamic and humoral changes after liver transplantation in patients with cirrhosis. Hepatology 1993; 17: 355-60
17. Moller S, Brinch K, Henriksen JH, Becker U. Effect of octreutide on systemic, central, and splanchnic haemodynamics in cirrhosis. J Hepatol 1997; 26: 1026-33
18. Escorsell A, Bandi JG, François E et al. Desensitation to the effects of intravenous octreotide in cirrhotic patients with portal hypertension. Hepatology 1996; 24: 207A
19. Gane EJ, Portmann BC, Naoumov NV et al. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996; 334: 815-20
20. Villamil FG, Vierling JM. Recurrence of viral hepatitis after liver transplantation: Insights into management. Liv Transplant and Surg 1995; 1: 89-99
21. Ferrel LD, Wright TL, Roberts J, Ascher N, Lake J. Hepatitis C viral infection in liver transplant recipients. Hepatology 1992; 16: 865-76
22. Lim HL, Lau GKK, Davis GL, Dolson DJ, Lau JYN. Cholestatic hepatitis leading to hepatic failure in a patient with organ-transmitted hepatitis C virus infection. Gastroenterology 1994; 106: 248-51
23. Schluger LK, Min A, Wolf DC et al. Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation. Gastroenterology 1994; 106: 978A
24. Kitayama Y, Yamanaka N, Kawamura E, Kuroda N, Okamoto E. Hepatoprotective effect of the endothelin receptor antagonist TAK-044 against ischemia-reperfusion injury in the canine liver. Hepatology 1997; 25: 938-42